159 related articles for article (PubMed ID: 32562583)
1. Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression.
Bryant MK; Ward C; Gaber CE; Strassle PD; Ollila DW; Laks S
J Surg Oncol; 2020 Sep; 122(4):653-659. PubMed ID: 32562583
[TBL] [Abstract][Full Text] [Related]
2. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis.
McEvoy AM; Lachance K; Hippe DS; Cahill K; Moshiri Y; Lewis CW; Singh N; Park SY; Thuesmunn Z; Cook MM; Alexander NA; Zawacki L; Thomas H; Paulson KG; Nghiem P
JAMA Dermatol; 2022 Apr; 158(4):382-389. PubMed ID: 35195657
[TBL] [Abstract][Full Text] [Related]
3. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
4. Effect of Patient Immune Status on the Efficacy of Radiation Therapy and Recurrence-Free Survival Among 805 Patients With Merkel Cell Carcinoma.
Tseng YD; Nguyen MH; Baker K; Cook M; Redman M; Lachance K; Bhatia S; Liao JJ; Apisarnthanarax S; Nghiem PT; Parvathaneni U
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):330-339. PubMed ID: 30191867
[TBL] [Abstract][Full Text] [Related]
5. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
6. MCPyV-Negative Merkel Cell Carcinoma In Situ Associated With Immunosuppression.
Mazumder A; Khoshnoodi P; Gruber J; Burkemper NM
Am J Dermatopathol; 2023 Apr; 45(4):242-245. PubMed ID: 36806258
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and prognosis of Merkel cell carcinoma: a single-center retrospective study in Korea.
Moon IJ; Na H; Cho HS; Won CH; Chang SE; Lee MW; Lee WJ
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10065-10074. PubMed ID: 37261524
[TBL] [Abstract][Full Text] [Related]
8. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
Arron ST; Canavan T; Yu SS
J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
[TBL] [Abstract][Full Text] [Related]
9. Insights into anti-tumor immunity
Jani S; Church CD; Nghiem P
Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
[TBL] [Abstract][Full Text] [Related]
10. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
Mistry K; Levell NJ; Hollestein L; Wakkee M; Nijsten T; Knott CS; Steven NM; Craig PJ; Venables ZC
Br J Dermatol; 2023 Feb; 188(2):228-236. PubMed ID: 36763882
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma.
Koljonen V; Kukko H; Pukkala E; Sankila R; Böhling T; Tukiainen E; Sihto H; Joensuu H
Br J Cancer; 2009 Oct; 101(8):1444-7. PubMed ID: 19755994
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, Clinicopathological and Virological Features of Merkel Cell Carcinomas in Medical Center of University of Pécs, Hungary (2007-2012).
Horváth KB; Pankovics P; Kálmán E; Kádár Z; Battyáni Z; Lengyel Z; Reuter G
Pathol Oncol Res; 2016 Jan; 22(1):71-7. PubMed ID: 26306468
[TBL] [Abstract][Full Text] [Related]
14. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Vlahova L; Doerflinger Y; Houben R; Becker JC; Schrama D; Weiss C; Goebeler M; Helmbold P; Goerdt S; Peitsch WK
Br J Dermatol; 2012 May; 166(5):1043-52. PubMed ID: 22283194
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Merkel Cell Polyomavirus Infection and Merkel Cell Carcinoma.
Silling S; Kreuter A; Gambichler T; Meyer T; Stockfleth E; Wieland U
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551657
[TBL] [Abstract][Full Text] [Related]
17. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma in immunosuppressed patients.
Ma JE; Brewer JD
Cancers (Basel); 2014 Jun; 6(3):1328-50. PubMed ID: 24978436
[TBL] [Abstract][Full Text] [Related]
19. Immune status and the efficacy of radiotherapy on overall survival for patients with localized Merkel cell carcinoma: An analysis of the National Cancer Database.
Yusuf MB; Gaskins J; Wall W; Tennant P; Bumpous J; Dunlap N
J Med Imaging Radiat Oncol; 2020 Jun; 64(3):435-443. PubMed ID: 32372566
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
